Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

The Evaluation of Policies on 2009 Influenza Pandemic in Korea

2009년 발생한 신종인플루엔자 대유행에 대한 정책적 대응 평가

  • Choi, Won-Suk (Division of Infectious Disease, Department of Internal Medicine, Korea University College of Medicine) ;
  • Kim, Woo-Joo (Division of Infectious Disease, Department of Internal Medicine, Korea University College of Medicine) ;
  • Cheong, Hee-Jin (Division of Infectious Disease, Department of Internal Medicine, Korea University College of Medicine)
  • 최원석 (고려대학교 의과대학 내과학교실 감염내과) ;
  • 김우주 (고려대학교 의과대학 내과학교실 감염내과) ;
  • 정희진 (고려대학교 의과대학 내과학교실 감염내과)
  • Published : 2010.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: To evaluate the policies on 2009 influenza pandemic in Korea at the end of first wave. Methods: The main policies and the estimation of these were described according to the progress of 2009 influenza pandemic. Results: The public health measures for containment were estimated to be successful in the early stage. The preparedness of antiviral agents and vaccines before the pandemic, risk-communication on pandemic influenza and policies of government including vaccines, and the education of health care worker and support of health care institutions was not enough to respond to the pandemic. Conclusions: The additional evaluation should be performed at the end of the pandemic in various aspects including health and socioeconomic effects.

Keywords

References

  1. WHO. 2009 updated 2009 June 11. [cited 2010 Feb 14]. Available from: http://www.who.int/media-centre/news/statements/2009/h1n1_pandemic_phase6_20090611/ en/index.html.
  2. KCDC. Influenza Sentinel Surveillance Report Number 2 - 2010. Seoul: Korea Center for Disease Control and Prevention; 2010.
  3. Lowen AC, Steel J, Mubareka S, Palese P. High temperature (30 degrees C) blocks aerosol but not contact transmission of influenza virus. J Virol 2008; 82(11): 5650- 5652. https://doi.org/10.1128/JVI.00325-08
  4. IDSC. 2009 updated 2009 May 23. [cited 2010 Feb 11]. Available from: http://idsc.nih.go.jp/disease/ swine_influenza_e/idsc_e2009/09idsc11e.html.
  5. IDSC. 2009 updated 2009 May 23. [cited 2010 Feb 11]. Available from: http://idsc.nih.go.jp/disease/ swine_influenza_e/idsc_e2009/09idsc11e.html.
  6. KCDC. 2010 updated 2010 Feb 8. [cited 2010 Feb 14]. Available from:http://www.cdc.go.kr/kcdchome/jsp/home/common/brd/COMMBRD0200Detail.jsp?boardid=1002&boardseq=22300&menuid=100039&appid=kcdchome&contentid=null&pageNum=2&tabinx=1&pageN o=&q_value=&q_name=&sub=1.

Cited by

  1. Evaluation of the Correspondence against Pandemic Influenza (H1N1 2009) through the Infectious Diseases Specialist Survey vol.42, pp.2, 2010, https://doi.org/10.3947/ic.2010.42.2.87
  2. The Association of Lymphopenia with the Clinical Severity in the Korean Children Admitted to the Hospital with Pandemic (H1N1) 2009 Infection vol.43, pp.1, 2011, https://doi.org/10.3947/ic.2011.43.1.36
  3. Neurologic Complications and Outcomes of Pandemic (H1N1) 2009 in Korean Children vol.27, pp.4, 2010, https://doi.org/10.3346/jkms.2012.27.4.402
  4. Neurologic Complications and Outcomes of Pandemic (H1N1) 2009 in Korean Children vol.27, pp.4, 2010, https://doi.org/10.3346/jkms.2012.27.4.403
  5. 신종플루 유행에 대한 보건소 담당자의 대응평가와 관련 요인 vol.23, pp.1, 2010, https://doi.org/10.4332/kjhpa.2013.23.1.052
  6. Antiviral therapy in seasonal influenza and 2009 H1N1 pandemic influenza: Korean experiences and perspectives vol.13, pp.11, 2010, https://doi.org/10.1586/14787210.2015.1076334
  7. Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly su vol.13, pp.7, 2017, https://doi.org/10.1080/21645515.2017.1297351
  8. Management of the COVID-19 Pandemic in the Republic of Korea from the Perspective of Governance and Public-Private Partnership vol.62, pp.9, 2010, https://doi.org/10.3349/ymj.2021.62.9.777